Axa’s Bicycle Therapeutics BCYC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.95M Sell
280,152
-273,530
-49% -$1.9M 0.01% 775
2025
Q1
$4.7M Sell
553,682
-277
-0.1% -$2.35K 0.02% 560
2024
Q4
$7.76M Sell
553,959
-440
-0.1% -$6.16K 0.02% 432
2024
Q3
$12.5M Buy
554,399
+79
+0% +$1.79K 0.04% 360
2024
Q2
$11.2M Buy
554,320
+157
+0% +$3.18K 0.03% 376
2024
Q1
$13.8M Buy
554,163
+77
+0% +$1.92K 0.04% 341
2023
Q4
$10M Sell
554,086
-20,981
-4% -$379K 0.03% 392
2023
Q3
$11.6M Buy
575,067
+21,435
+4% +$431K 0.04% 365
2023
Q2
$14.1M Buy
553,632
+93,507
+20% +$2.39M 0.05% 345
2023
Q1
$9.79M Buy
460,125
+79,570
+21% +$1.69M 0.03% 418
2022
Q4
$11.3M Sell
380,555
-30,085
-7% -$891K 0.04% 416
2022
Q3
$9.55M Sell
410,640
-52,387
-11% -$1.22M 0.04% 440
2022
Q2
$7.77M Buy
463,027
+317,773
+219% +$5.33M 0.03% 478
2022
Q1
$6.37M Buy
145,254
+2
+0% +$88 0.02% 582
2021
Q4
$8.84M Sell
145,252
-53,421
-27% -$3.25M 0.02% 531
2021
Q3
$8.26M Buy
198,673
+1,163
+0.6% +$48.4K 0.02% 547
2021
Q2
$6M Sell
197,510
-289
-0.1% -$8.77K 0.02% 657
2021
Q1
$5.91M Buy
197,799
+52,802
+36% +$1.58M 0.02% 666
2020
Q4
$2.6M Buy
+144,997
New +$2.6M 0.01% 810